|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Paraquat results in decreased secretion of AGER protein modified form]; Febuxostat inhibits the reaction [Paraquat results in increased expression of AGER mRNA] |
CTD |
PMID:30726711 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of BAX protein] |
CTD |
PMID:26036690 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] |
CTD |
PMID:26036690 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] |
CTD |
PMID:26036690 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Febuxostat results in increased expression of CCL2 mRNA |
CTD |
PMID:26641773 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Paraquat results in increased expression of CTNNB1 protein] |
CTD |
PMID:30726711 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
ISO |
Febuxostat results in increased expression of DUSP10 mRNA |
CTD |
PMID:35866629 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
increases expression |
ISO |
Febuxostat results in increased expression of DUSP4 mRNA |
CTD |
PMID:35866629 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
Febuxostat results in increased expression of DUSP5 mRNA |
CTD |
PMID:35866629 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
ISO |
Febuxostat results in increased expression of DUSP8 mRNA |
CTD |
PMID:35866629 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
Febuxostat results in increased expression of GADD45G mRNA |
CTD |
PMID:35866629 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
multiple interactions |
ISO |
Febuxostat inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) co-treated with Freund's Adjuvant] results in decreased expression of GOT2 mRNA]; Febuxostat inhibits the reaction [[myelin oligodendrocyte glycoprotein (35-55) co-treated with Freund's Adjuvant] results in decreased expression of GOT2 protein] |
CTD |
PMID:29107957 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Paraquat results in increased expression of HMGB1 mRNA] |
CTD |
PMID:30726711 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of IKBKB protein] |
CTD |
PMID:26036690 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il1rap |
interleukin 1 receptor accessory protein |
increases expression |
ISO |
Febuxostat results in increased expression of IL1RAP mRNA |
CTD |
PMID:35866629 |
|
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
Febuxostat results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:35866629 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Paraquat results in increased expression of MMP9 protein] |
CTD |
PMID:30726711 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mras |
muscle RAS oncogene homolog |
increases expression |
ISO |
Febuxostat results in increased expression of MRAS mRNA |
CTD |
PMID:35866629 |
|
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of NPPB protein] |
CTD |
PMID:26036690 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases expression |
ISO |
Febuxostat results in increased expression of NR4A1 mRNA |
CTD |
PMID:35866629 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Paraquat results in increased expression of PTGS2 mRNA] |
CTD |
PMID:30726711 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of RELA protein] |
CTD |
PMID:26036690 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] |
CTD |
PMID:26036690 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
Febuxostat inhibits the reaction [Doxorubicin results in increased expression of TNF protein] Febuxostat results in increased expression of TNF mRNA |
CTD |
PMID:26036690 PMID:26641773 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
Febuxostat inhibits the reaction [Paraquat results in increased expression of VEGFA protein] |
CTD |
PMID:30726711 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xdh |
xanthine dehydrogenase |
decreases activity |
ISO |
Febuxostat results in decreased activity of XDH protein |
CTD |
PMID:35866629 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|